Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASI: 1600 mg Single Tablet Mesalazine for UC Adherence
NCT04133194Phase 4Unknown
- Start
- Nov 2019
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Salcrozine in ulcerative colitis (UC). Status: unknown.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04133194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133194.